Skip to main content

About this Research Topic

Manuscript Submission Deadline 10 March 2024

This Research Topic is still accepting articles. For authors aiming to contribute, please submit your manuscript today

Despite significant advancements in cancer care, pediatric oncologists face unique challenges due to the distinct characteristics of pediatric tumors, their vulnerability to treatment-related toxicities, and the need for long-term surveillance for potential late effects. Imaging plays a crucial role in the diagnosis, treatment planning, and monitoring of pediatric cancers. In recent years, there have been significant advancements in medical imaging technologies to accurately assess disease extent, guide interventions, and minimize radiation exposure in young patients.

Through this Research Topic, we aim to explore the latest advancements in imaging applications and their impact on diagnostic accuracy, therapeutic decision-making, and patient outcomes in pediatric cancers. We expect to provide a forum to advance the field and ultimately improve the care and outcomes for children battling cancer.

We invite researchers, clinicians, radiologists, pediatric oncologists, medical physicists, and other experts in related fields to contribute to this collection. Original research articles, review papers, and case studies are welcome. We accept submissions on, but not limited to:
- Imaging-guided interventions, guiding minimally invasive procedures.
- Multimodality imaging, including nuclear medicine studies.
- Imaging techniques for accurate tumor targeting and real-time monitoring, including age-appropriate protocols and safety considerations.
- Utility of molecular imaging for evaluating rare or atypical malignancies.
- Novel treatments, including theranostic, off-label use of radiopharmaceuticals.

Please note: Manuscripts consisting solely of bioinformatics, computational analysis, or predictions of public databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) will not be accepted in any of the sections of Frontiers in Oncology.

Keywords: children with cancer, molecular imaging, nuclear medicine, atypical cases, radiopharmaceuticals


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Despite significant advancements in cancer care, pediatric oncologists face unique challenges due to the distinct characteristics of pediatric tumors, their vulnerability to treatment-related toxicities, and the need for long-term surveillance for potential late effects. Imaging plays a crucial role in the diagnosis, treatment planning, and monitoring of pediatric cancers. In recent years, there have been significant advancements in medical imaging technologies to accurately assess disease extent, guide interventions, and minimize radiation exposure in young patients.

Through this Research Topic, we aim to explore the latest advancements in imaging applications and their impact on diagnostic accuracy, therapeutic decision-making, and patient outcomes in pediatric cancers. We expect to provide a forum to advance the field and ultimately improve the care and outcomes for children battling cancer.

We invite researchers, clinicians, radiologists, pediatric oncologists, medical physicists, and other experts in related fields to contribute to this collection. Original research articles, review papers, and case studies are welcome. We accept submissions on, but not limited to:
- Imaging-guided interventions, guiding minimally invasive procedures.
- Multimodality imaging, including nuclear medicine studies.
- Imaging techniques for accurate tumor targeting and real-time monitoring, including age-appropriate protocols and safety considerations.
- Utility of molecular imaging for evaluating rare or atypical malignancies.
- Novel treatments, including theranostic, off-label use of radiopharmaceuticals.

Please note: Manuscripts consisting solely of bioinformatics, computational analysis, or predictions of public databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) will not be accepted in any of the sections of Frontiers in Oncology.

Keywords: children with cancer, molecular imaging, nuclear medicine, atypical cases, radiopharmaceuticals


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Topic Editors

Loading..

Topic Coordinators

Loading..

Articles

Sort by:

Loading..

Authors

Loading..

total views

total views article views downloads topic views

}
 
Top countries
Top referring sites
Loading..

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.